A BILL TO BE ENTITLED
AN ACT enhancing standards for prescribing equivalent drug products by requiring these products to be labeled with the united states food and drug administration therapeutic equivalence code.
The General Assembly of North Carolina enacts:
SECTION 1.  G.S. 90‑85.28(a) reads as rewritten:
"(a)	A pharmacist dispensing a prescription for a drug product prescribed by its brand name may select any equivalent drug product which meets all of the following standards:
(1)	The manufacturer's name; the distributor's name, if different from the manufacturer's name; and the United States Food and Drug Administration therapeutic equivalence code shall appear on the label of the stock package.
(2)	It shall be manufactured in accordance with current good manufacturing practices.
(3)	All oral solid dosage forms shall have a logo, or other identification mark, or the product name to identify the manufacturer or distributor.
(4)	The manufacturer shall have adequate provisions for drug recall.
(5)	The manufacturer shall have adequate provisions for return of outdated drugs, through the distributor or otherwise."
SECTION 2.  This act becomes effective October 1, 2015.